5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine has been researched along with carbamazepine in 5 studies
| Studies (5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine) | Trials (5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine) | Recent Studies (post-2010) (5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine) | Studies (carbamazepine) | Trials (carbamazepine) | Recent Studies (post-2010) (carbamazepine) |
|---|---|---|---|---|---|
| 10 | 0 | 1 | 11,992 | 1,128 | 3,101 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anger, T; Madge, DJ; Mulla, M; Riddall, D | 1 |
| Grant, KA; Rogawski, MA; Snell, LD; Tabakoff, B; Thurkauf, A | 1 |
| Jones, SM; Monn, JA; Rice, KC; Rogawski, MA; Thurkauf, A; Yamaguchi, S | 1 |
| Seidleck, BK; Thurkauf, A; Witkin, JM | 1 |
| Lin, SS; Sun, L | 1 |
1 review(s) available for 5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine and carbamazepine
| Article | Year |
|---|---|
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke | 2001 |
4 other study(ies) available for 5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine and carbamazepine
| Article | Year |
|---|---|
Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizur
Topics: Animals; Anticonvulsants; Carbamazepine; Dizocilpine Maleate; Ethanol; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Seizures; Substance Withdrawal Syndrome; Tremor | 1992 |
Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D- aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine.
Topics: Administration, Oral; Animals; Anticonvulsants; Carbamazepine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Kindling, Neurologic; Male; Mice; Motor Activity; N-Methylaspartate; Rats; Rats, Inbred Strains; Seizures; Structure-Activity Relationship | 1991 |
Evaluation of ADCI against convulsant and locomotor stimulant effects of cocaine: comparison with the structural analogs dizocilpine and carbamazepine.
Topics: Animals; Anticonvulsants; Carbamazepine; Cocaine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Mice; Motor Activity; Receptors, N-Methyl-D-Aspartate; Seizures; Substance-Related Disorders | 1994 |
The anticonvulsant SGB-017 (ADCI) blocks voltage-gated sodium channels in rat and human neurons: comparison with carbamazepine.
Topics: Animals; Anticonvulsants; Carbamazepine; Cells, Cultured; Disease Models, Animal; Dizocilpine Maleate; Epilepsy; Hippocampus; Humans; Neurons; Patch-Clamp Techniques; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Sodium Channel Blockers; Sodium Channels; Superior Cervical Ganglion | 2000 |